AI assistant
BERKLEY W R CORP — Director's Dealing 2017
Nov 30, 2017
30178_dirs_2017-11-29_e3183536-3ed2-4113-8508-f5205ab26185.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HEALTHEQUITY INC (HQY)
CIK: 0001428336
Period of Report: 2017-11-27
Reporting Person: Berkley Capital, LLC (10% Owner)
Reporting Person: Berkley Capital Investors, L.P. (10% Owner)
Reporting Person: BERKLEY W R CORP (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-11-27 | Common Stock | S | 12300 | $52.1416 | Disposed | 6462032 | Indirect |
| 2017-11-29 | Common Stock | S | 700 | $52.045 | Disposed | 6461332 | Indirect |
Footnotes
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.01 to $52.26, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (3) to this Form 4.
F2: All securities are held of record by Berkley Capital Investors, L.P., a Delaware limited partnership ("Berkley Investors"). Berkley Capital, LLC, a Delaware limited liability company ("Berkley Capital") is the general partner of Berkley Investors. Berkley Capital is an indirect, wholly owned subsidiary of W. R. Berkley Corporation, a Delaware corporation ("W. R. Berkley"), and as such beneficial ownership of all securities held of record by Berkley Investors may be deemed attributable to W. R. Berkley.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.01 to $52.07, inclusive.